Next report date
Report period
H2 2023
EPS estimate
1.13MXN
Revenue estimate
10.33 BMXN
2.19MXN
2.87 BMXN
22.25 BMXN
555.92 M
About DR. MARTENS PLC ORD GBP0.01
Sector
Industry
CEO
Kenneth Charles Wilson
Website
Headquarters
London
Employees (FY)
2.59 K
Founded
1945
FIGI
BBG010L8YFQ8
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where DOCS/N is featured.
Frequently Asked Questions
The current price of DOCS/N is 29.87 MXN — it has decreased by 5.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange DR. MARTENS PLC stocks are traded under the ticker DOCS/N.
DR. MARTENS PLC is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
DOCS/N stock is 5.52% volatile and has beta coefficient of 2.03. Check out the list of the most volatile stocks — is DR. MARTENS PLC there?
DOCS/N earnings for the last quarter are 1.87 MXN per share, whereas the estimation was 2.17 MXN resulting in a −13.97% surprise. The estimated earnings for the next quarter are 0.40 MXN per share. See more details about DR. MARTENS PLC earnings.
DR. MARTENS PLC revenue for the last quarter amounts to 12.94 B MXN despite the estimated figure of 12.92 B MXN. In the next quarter revenue is expected to reach 8.47 B MXN.
Yes, you can track DR. MARTENS PLC financials in yearly and quarterly reports right on TradingView.
DOCS/N net income for the last quarter is 403.94 M MXN, while the quarter before that showed 1.87 B MXN of net income which accounts for −78.43% change. Track more DR. MARTENS PLC financial stats to get the full picture.
Today DR. MARTENS PLC has the market capitalization of 15.03 B, it has decreased by 4.92% over the last week.
DR. MARTENS PLC dividend yield was 4.10% in 2022, and payout ratio reached 45.34%. The year before the numbers were 2.30% and 30.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, DOCS/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. MARTENS PLC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 2.59 K employees. See our rating of the largest employees — is DR. MARTENS PLC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. MARTENS PLC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. MARTENS PLC stock shows the neutral signal. See more of DR. MARTENS PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DR. MARTENS PLC future price: according to them, DOCS/N price has a max estimate of 23.67 MXN and a min estimate of 13.99 MXN. Read a more detailed DR. MARTENS PLC forecast: see what analysts think of DR. MARTENS PLC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. MARTENS PLC EBITDA is 4.96 B MXN, and current EBITDA margin is 24.49%. See more stats in DR. MARTENS PLC financial statements.